Building AI in Healthcare: BioticsAI CEO Shares Lessons from FDA Approval and Fundraising

BioticsAI CEO Robhy Bustami recently shared his experiences on the podcast Build Mode, offering a candid look at the hurdles of developing AI in healthcare. He emphasized the complexity of obtaining FDA approval and the importance of maintaining team morale through the lengthy process. Bustami's insights provide a rare glimpse into the realities of operating in a highly regulated industry.

For those outside the healthcare industry, think of FDA approval like getting a driver's license for your AI. It's not just about proving your technology works; it's about showing it's safe and reliable under a wide range of conditions. This process can be grueling, but it's essential for gaining trust and adoption in the medical field. Bustami's advice is particularly relevant for anyone considering entering this space, as it underscores the need for patience and persistence.

If you're interested in AI and healthcare, Bustami's interview is a must-listen. It offers practical advice on navigating regulatory hurdles and maintaining team motivation. Keep an eye out for similar discussions from other healthcare AI pioneers, as their experiences can provide valuable lessons for both aspiring entrepreneurs and seasoned professionals.